title: Blizzard deals. In a sure sign of a robust industry, companies recently have gotten in the spirit to merge and acquire.
abstract: The holiday season has brought a flurry of healthcare mergers and acquisitions, including Johnson & Johnson's possible deal with Guidant Corp., and DaVita's move for Gambro Healthcare US. Antitrust concerns may force Gambro to divest up to 100 dialysis centers before the deal can close, says Darren Lehrich, left, an analyst with Piper Jaffray & Co.
authors.forename: Vince
authors.initials: V
authors.lastname: Galloro
mesh_terms: D004345:Drug Industry / Q000458:organization & administration / Q000639:trends; D004465:Economic Competition / Q000639:trends; D004864:Equipment and Supplies / Q000191:economics; D005380:Financing, Government; D019981:Health Care Sector / Q000458:organization & administration* / Q000639:trends; D006273:Health Facility Merger / Q000639:trends; D017721:Hospital Costs / Q000639:trends; D007449:Investments; D009935:Organizational Affiliation; D014481:United States